Bulletin
Investor Alert

Elanco Animal Health Inc.

NYS: ELAN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 25, 2021, 6:18 p.m.

/zigman2/quotes/203710302/composite

$

29.05

Change

-4.92 -14.48%

Volume

Volume 51,561

Quotes are delayed by 20 min

/zigman2/quotes/203710302/composite

Today's close

$ 33.90

$ 33.97

Change

+0.07 +0.21%

Day low

Day high

$33.69

$34.19

Open

52 week low

52 week high

$26.72

$37.49

Open

Annual Financials for Elanco Animal Health Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 2.91B2.89B3.07B3.07B3.27B
Cost of Goods Sold (COGS) incl. D&A 1.58B1.72B1.77B1.67B2.03B
COGS excluding D&A 1.33B1.4B1.48B1.36B1.51B
Depreciation & Amortization Expense 254.4M318.4M296M314.5M516.9M
Depreciation 83.7M97.2M98.6M93.7M157M
Amortization of Intangibles 170.7M221.2M197.4M220.8M359.9M
Gross Income 1.33B1.17B1.3B1.4B1.25B
20162017201820192020 5-year trend
SG&A Expense 1.05B1.03B981.8M1.03B1.32B
Research & Development 265.8M251.7M246.6M270.1M327M
Other SG&A 784.8M779.8M735.2M760.2M996.6M
Other Operating Expense -----
Unusual Expense 308.4M394.7M167.2M193M625.3M
EBIT after Unusual Expense (25.2M)(252.3M)146.6M177M(702.1M)
Non Operating Income/Expense 2.8M19.7M(2.9M)(19.9M)186.1M
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense --29.6M78.9M156M
Gross Interest Expense --29.6M78.9M156M
Interest Capitalized -----
Pretax Income (22.4M)(232.6M)114.1M78.2M(672M)
Income Tax 25.5M78.1M27.6M10.3M(111.9M)
Income Tax - Current Domestic 300,000(100,000)42.8M(3.2M)(42.7M)
Income Tax - Current Foreign 31.1M91.6M45.5M13.4M55.6M
Income Tax - Deferred Domestic 20.9M3.2M(55.1M)7.6M(100,000)
Income Tax - Deferred Foreign (26.8M)(16.6M)(5.6M)(7.5M)(124.7M)
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (47.9M)(310.7M)86.5M67.9M(560.1M)
Minority Interest Expense -----
Net Income (47.9M)(310.7M)86.5M67.9M(560.1M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (47.9M)(310.7M)86.5M67.9M(560.1M)
Preferred Dividends -----
Net Income Available to Common (47.9M)(310.7M)86.5M67.9M(560.1M)
EPS (Basic) ----(1.27)
Basic Shares Outstanding ----441.4M
EPS (Diluted) ----(1.27)
Diluted Shares Outstanding ----441.4M
EBITDA 537.6M460.8M609.8M684.5M440.1M
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.